(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC19A2 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC19A2 mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO Slc19a2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC19A2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of SLC19A2 mRNA CTD PMID:25380136 17beta-estradiol multiple interactions ISO SLC19A2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SLC19A2 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO SLC19A2 (Homo sapiens) 6480464 Estradiol results in increased expression of SLC19A2 mRNA CTD PMID:36828454 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC19A2 mRNA CTD PMID:32145629 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO SLC19A2 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of SLC19A2 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:31826744 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO SLC19A2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC19A2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC19A2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO SLC19A2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC19A2 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc19a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC19A2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC19A2 mRNA CTD PMID:21215274 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of SLC19A2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of SLC19A2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO SLC19A2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of SLC19A2 mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine decreases expression ISO Slc19a2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of SLC19A2 mRNA CTD PMID:26251327 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression ISO Slc19a2 (Mus musculus) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A2 mRNA and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A2 protein CTD PMID:24244374 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A2 protein] which results in decreased uptake of Thiamine CTD PMID:24244374 4-hydroxyphenyl retinamide increases expression ISO Slc19a2 (Mus musculus) 6480464 Fenretinide results in increased expression of SLC19A2 mRNA CTD PMID:28973697 7,12-dimethyltetraphene increases expression ISO Slc19a2 (Mus musculus) 6480464 9 more ... CTD PMID:32553695 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC19A2 mRNA CTD PMID:31881176 aflatoxin B1 decreases methylation ISO SLC19A2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of SLC19A2 gene CTD PMID:27153756 aristolochic acid A decreases expression ISO SLC19A2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SLC19A2 mRNA CTD PMID:33212167 arsenite(3-) affects expression ISO SLC19A2 (Homo sapiens) 6480464 arsenite affects the expression of SLC19A2 mRNA CTD PMID:22959463 atrazine increases expression ISO SLC19A2 (Homo sapiens) 6480464 Atrazine results in increased expression of SLC19A2 mRNA CTD PMID:22378314 benzo[a]pyrene affects expression ISO SLC19A2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the expression of SLC19A2 mRNA CTD PMID:20106945 benzo[a]pyrene multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC19A2 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO SLC19A2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of SLC19A2 mRNA CTD PMID:21632981 more ... benzo[a]pyrene increases expression ISO Slc19a2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLC19A2 mRNA CTD PMID:21569818 more ... benzo[b]fluoranthene increases expression ISO Slc19a2 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of SLC19A2 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC19A2 mRNA CTD PMID:27858113 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC19A2 mRNA and [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC19A2 mRNA CTD PMID:18164116 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC19A2 mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO Slc19a2 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC19A2 mRNA CTD PMID:33221593 bisphenol A increases expression ISO SLC19A2 (Homo sapiens) 6480464 bisphenol A results in increased expression of SLC19A2 mRNA CTD PMID:36828454 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC19A2 mRNA CTD PMID:32145629 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC19A2 gene CTD PMID:28505145 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of SLC19A2 mRNA CTD PMID:32479839 cadmium dichloride increases expression ISO Slc19a2 (Mus musculus) 6480464 Cadmium Chloride results in increased expression of SLC19A2 mRNA CTD PMID:20883709 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SLC19A2 mRNA CTD PMID:33453195 caffeine decreases phosphorylation ISO SLC19A2 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of SLC19A2 protein CTD PMID:35688186 carbamazepine affects expression ISO SLC19A2 (Homo sapiens) 6480464 Carbamazepine affects the expression of SLC19A2 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO Slc19a2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO Slc19a2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carmustine decreases expression EXP 6480464 Carmustine results in decreased expression of SLC19A2 mRNA CTD PMID:16005536 chloroprene increases expression ISO Slc19a2 (Mus musculus) 6480464 Chloroprene results in increased expression of SLC19A2 mRNA CTD PMID:23125180 choline multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC19A2 mRNA CTD PMID:20938992 chrysene multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC19A2 mRNA CTD PMID:27858113 cisplatin multiple interactions ISO SLC19A2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SLC19A2 mRNA CTD PMID:27392435 copper(II) sulfate decreases expression ISO SLC19A2 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of SLC19A2 mRNA CTD PMID:19549813 crocidolite asbestos affects expression ISO SLC19A2 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of SLC19A2 mRNA CTD PMID:25757056 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SLC19A2 mRNA CTD PMID:26577399 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SLC19A2 mRNA CTD PMID:27523638 cyclosporin A affects expression ISO SLC19A2 (Homo sapiens) 6480464 Cyclosporine affects the expression of SLC19A2 mRNA CTD PMID:25562108 cyclosporin A increases expression ISO SLC19A2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of SLC19A2 mRNA CTD PMID:27989131 desferrioxamine B decreases expression ISO SLC19A2 (Homo sapiens) 6480464 Deferoxamine results in decreased expression of SLC19A2 mRNA CTD PMID:34998824 dexamethasone increases expression ISO SLC19A2 (Homo sapiens) 6480464 Dexamethasone results in increased expression of SLC19A2 mRNA CTD PMID:25047013 dibenz[a,h]anthracene increases expression ISO Slc19a2 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 diclofenac increases expression ISO Slc19a2 (Mus musculus) 6480464 Diclofenac results in increased expression of SLC19A2 mRNA CTD PMID:35537566 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of SLC19A2 mRNA CTD PMID:23153324 dioxygen multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC19A2 mRNA CTD PMID:30529165 dioxygen decreases expression ISO SLC19A2 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of SLC19A2 mRNA and Oxygen deficiency results in decreased expression of SLC19A2 protein CTD PMID:34998824 dioxygen multiple interactions ISO SLC19A2 (Homo sapiens) 6480464 HIF1A protein affects the reaction [Oxygen deficiency results in decreased expression of SLC19A2 protein] CTD PMID:34998824 doxorubicin increases expression ISO SLC19A2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of SLC19A2 mRNA CTD PMID:29803840 elemental selenium decreases expression ISO SLC19A2 (Homo sapiens) 6480464 Selenium results in decreased expression of SLC19A2 mRNA CTD PMID:19244175 elesclomol multiple interactions ISO SLC19A2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC19A2 mRNA] CTD PMID:18723479 elesclomol increases expression ISO SLC19A2 (Homo sapiens) 6480464 elesclomol results in increased expression of SLC19A2 mRNA CTD PMID:18723479 fenthion decreases expression ISO Slc19a2 (Mus musculus) 6480464 Fenthion results in decreased expression of SLC19A2 mRNA CTD PMID:34813904 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC19A2 mRNA CTD PMID:24136188 folic acid multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC19A2 mRNA CTD PMID:20938992 folic acid decreases expression ISO Slc19a2 (Mus musculus) 6480464 Folic Acid results in decreased expression of SLC19A2 mRNA CTD PMID:25629700 FR900359 affects phosphorylation ISO SLC19A2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of SLC19A2 protein CTD PMID:37730182 furan decreases expression EXP 6480464 furan results in decreased expression of SLC19A2 mRNA CTD PMID:25539665 and PMID:26194646 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC19A2 mRNA CTD PMID:33387578 heptachlor decreases expression EXP 6480464 Heptachlor results in decreased expression of SLC19A2 mRNA CTD PMID:23153324 hydralazine multiple interactions ISO SLC19A2 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC19A2 mRNA CTD PMID:17183730 indometacin increases expression ISO SLC19A2 (Homo sapiens) 6480464 Indomethacin results in increased expression of SLC19A2 mRNA CTD PMID:16984733 inulin multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC19A2 mRNA CTD PMID:36331819 L-methionine multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC19A2 mRNA CTD PMID:20938992 leflunomide increases expression ISO Slc19a2 (Mus musculus) 6480464 leflunomide results in increased expression of SLC19A2 mRNA CTD PMID:19751817 leflunomide increases expression ISO SLC19A2 (Homo sapiens) 6480464 leflunomide results in increased expression of SLC19A2 mRNA CTD PMID:28988120 melphalan increases expression ISO SLC19A2 (Homo sapiens) 6480464 Melphalan results in increased expression of SLC19A2 mRNA CTD PMID:22363485 metformin decreases expression EXP 6480464 Metformin results in decreased expression of SLC19A2 mRNA CTD PMID:31324951 methidathion decreases expression ISO Slc19a2 (Mus musculus) 6480464 methidathion results in decreased expression of SLC19A2 mRNA CTD PMID:34813904 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of SLC19A2 mRNA CTD PMID:16005536 mirex decreases expression EXP 6480464 Mirex results in decreased expression of SLC19A2 mRNA CTD PMID:23153324 N-acetyl-L-cysteine multiple interactions ISO SLC19A2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC19A2 mRNA] CTD PMID:18723479 N-nitrosodiethylamine increases expression ISO Slc19a2 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of SLC19A2 mRNA CTD PMID:17942915 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of SLC19A2 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC19A2 mRNA and [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC19A2 mRNA CTD PMID:18164116 N-nitrosodiethylamine multiple interactions ISO Slc19a2 (Mus musculus) 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SLC19A2 mRNA] CTD PMID:17942915 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of SLC19A2 mRNA CTD PMID:25380136 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of SLC19A2 mRNA CTD PMID:24136188 nickel sulfate decreases expression ISO SLC19A2 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of SLC19A2 mRNA CTD PMID:22714537 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of SLC19A2 mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC19A2 mRNA CTD PMID:25729387 ozone increases expression EXP 6480464 Ozone results in increased expression of SLC19A2 mRNA CTD PMID:28623178 ozone multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC19A2 mRNA CTD PMID:34911549 paracetamol affects expression ISO Slc19a2 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC19A2 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC19A2 mRNA CTD PMID:33387578 paracetamol increases expression ISO SLC19A2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SLC19A2 mRNA CTD PMID:21420995 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SLC19A2 mRNA CTD PMID:32680482 perfluorooctane-1-sulfonic acid decreases expression ISO SLC19A2 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC19A2 mRNA CTD PMID:32790152 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC19A2 mRNA more ... CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO SLC19A2 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of SLC19A2 mRNA CTD PMID:32790152 phenobarbital affects expression ISO SLC19A2 (Homo sapiens) 6480464 Phenobarbital affects the expression of SLC19A2 mRNA CTD PMID:19159669 pirinixic acid decreases expression ISO Slc19a2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC19A2 mRNA CTD PMID:18445702 pregnenolone 16alpha-carbonitrile decreases expression ISO Slc19a2 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC19A2 mRNA CTD PMID:28903501 progesterone increases expression ISO SLC19A2 (Homo sapiens) 6480464 Progesterone results in increased expression of SLC19A2 mRNA CTD PMID:21795739 rac-lactic acid increases expression ISO SLC19A2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of SLC19A2 mRNA CTD PMID:30851411 selenium atom decreases expression ISO SLC19A2 (Homo sapiens) 6480464 Selenium results in decreased expression of SLC19A2 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO SLC19A2 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of SLC19A2 mRNA CTD PMID:25351596 sodium arsenite increases expression ISO Slc19a2 (Mus musculus) 6480464 sodium arsenite results in increased expression of SLC19A2 mRNA CTD PMID:20883709 sunitinib increases expression ISO SLC19A2 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLC19A2 mRNA CTD PMID:31533062 tert-butyl hydroperoxide increases expression ISO SLC19A2 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of SLC19A2 mRNA CTD PMID:15336504 tetrachloromethane affects expression ISO Slc19a2 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of SLC19A2 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of SLC19A2 mRNA CTD PMID:29987408 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC19A2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC19A2 mRNA CTD PMID:31150632 tetraphene multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC19A2 mRNA CTD PMID:27858113 thiamine(1+) chloride increases uptake ISO SLC19A2 (Homo sapiens) 6480464 SLC19A2 protein results in increased uptake of Thiamine CTD PMID:16705148 thiamine(1+) chloride multiple interactions ISO Slc19a2 (Mus musculus) 6480464 [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A2 protein] which results in decreased uptake of Thiamine CTD PMID:24244374 thiamine(1+) chloride increases uptake ISO Slc19a2 (Mus musculus) 6480464 SLC19A2 protein results in increased uptake of Thiamine CTD PMID:24244374 thiamine(1+) chloride increases expression ISO SLC19A2 (Homo sapiens) 6480464 Thiamine deficiency results in increased expression of SLC19A2 mRNA and Thiamine deficiency results in increased expression of SLC19A2 protein CTD PMID:16705148 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC19A2 mRNA CTD PMID:23411599 tioguanine decreases expression EXP 6480464 Thioguanine results in decreased expression of SLC19A2 mRNA CTD PMID:16005536 titanium dioxide decreases expression ISO Slc19a2 (Mus musculus) 6480464 titanium dioxide results in decreased expression of SLC19A2 mRNA CTD PMID:29264374 topotecan increases expression EXP 6480464 Topotecan results in increased expression of SLC19A2 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC19A2 mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC19A2 mRNA CTD PMID:33387578 troglitazone decreases expression ISO Slc19a2 (Mus musculus) 6480464 troglitazone results in decreased expression of SLC19A2 mRNA CTD PMID:28973697 trovafloxacin increases expression ISO Slc19a2 (Mus musculus) 6480464 trovafloxacin results in increased expression of SLC19A2 mRNA CTD PMID:35537566 tungsten increases expression ISO Slc19a2 (Mus musculus) 6480464 Tungsten results in increased expression of SLC19A2 mRNA CTD PMID:30912803 valproic acid multiple interactions ISO SLC19A2 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC19A2 mRNA CTD PMID:17183730 valproic acid increases expression ISO SLC19A2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC19A2 mRNA CTD PMID:26272509 and PMID:29154799 valproic acid affects expression ISO Slc19a2 (Mus musculus) 6480464 Valproic Acid affects the expression of SLC19A2 mRNA CTD PMID:17292431 valproic acid decreases methylation ISO SLC19A2 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of SLC19A2 gene CTD PMID:29154799 valproic acid affects expression ISO SLC19A2 (Homo sapiens) 6480464 Valproic Acid affects the expression of SLC19A2 mRNA CTD PMID:25979313 zearalenone increases expression ISO SLC19A2 (Homo sapiens) 6480464 Zearalenone results in increased expression of SLC19A2 mRNA CTD PMID:36828454 zidovudine decreases expression ISO SLC19A2 (Homo sapiens) 6480464 Zidovudine results in decreased expression of SLC19A2 mRNA CTD PMID:24292225